SunMax Biotechnology Co. Ltd.(TW:4728)
NT$388.000.00 (0.00%)
TW:4728
SunMax Biotechnology Co. Ltd. financials statements
NT$388.00
At close:0.00 (0.00%)
SunMax Biotechnology Co. Ltd. (4728) Income Statement
SunMax Biotechnology Co. Ltd. Income Statement
Last quarter (Q2 2026), SunMax Biotechnology Co. Ltd.'s total revenue was NT$618.26M, an increase of 34.37% from the same quarter last year. In Q2, SunMax Biotechnology Co. Ltd.'s net income was NT$242.42M. See SunMax Biotechnology Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 2.03B | NT$ 1.82B | NT$ 1.69B | NT$ 1.40B | NT$ 1.04B | |
| NT$ 1.59B | NT$ 735.15M | NT$ 1.40B | NT$ 1.19B | NT$ 894.45M | |
| NT$ 590.32M | NT$ 195.64M | NT$ 510.10M | NT$ 425.19M | NT$ 526.83M | |
| Depreciation and Amortization | NT$ 102.31M | NT$ 71.05M | NT$ 72.83M | NT$ 58.15M | NT$ 55.76M |
| NT$ 1.10B | NT$ 911.19M | NT$ 985.16M | NT$ 836.35M | NT$ 415.70M | |
| NT$ 998.31M | NT$ 926.96M | NT$ 894.79M | NT$ 777.68M | NT$ 362.63M | |
| NT$ 16.27M | NT$ 26.31M | NT$ 14.60M | NT$ -499.00K | NT$ -10.13M | |
| NT$ 1.01B | NT$ 953.28M | NT$ 909.39M | NT$ 777.18M | NT$ 357.49M | |
| NT$ 725.75M | NT$ 679.40M | NT$ 625.71M | NT$ 533.83M | NT$ 245.64M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 13.33 | NT$ 12.47 | NT$ 11.49 | NT$ 9.80 | NT$ 4.51 |
| Diluted EPS | NT$ 13.33 | NT$ 12.47 | NT$ 11.47 | NT$ 9.79 | NT$ 4.51 |
| Weighted Average Shares Outstanding | 54.45M | 54.46M | 54.46M | 54.46M | 54.46M |
| Weighted Average Shares Outstanding (Diluted) | 54.45M | 54.54M | 54.53M | 54.54M | 54.52M |
Currency in TWD
